
Sign up to save your podcasts
Or
Lupus nephritis, affecting nearly half of lupus patients, can cause severe kidney damage. Traditionally, high-dose glucocorticoids (~1 mg per kg prednisone) have been used despite significant side effects. In this episode, host Anna Wolska speaks with Dr. Amit Saxena, a rheumatologist and Associate Professor at NYU Langone Health, about his recent research on the use of glucocorticoids in treating kidney disease in lupus. His study pooled standard-of-care arms from several major clinical trials to compare the efficacy and safety of lower versus higher oral glucocorticoid doses—administered after an initial IV steroid pulse—in treating lupus nephritis.
Read the article published in LSM - https://doi.org/10.1136/lupus-2024-001351
3.9
1414 ratings
Lupus nephritis, affecting nearly half of lupus patients, can cause severe kidney damage. Traditionally, high-dose glucocorticoids (~1 mg per kg prednisone) have been used despite significant side effects. In this episode, host Anna Wolska speaks with Dr. Amit Saxena, a rheumatologist and Associate Professor at NYU Langone Health, about his recent research on the use of glucocorticoids in treating kidney disease in lupus. His study pooled standard-of-care arms from several major clinical trials to compare the efficacy and safety of lower versus higher oral glucocorticoid doses—administered after an initial IV steroid pulse—in treating lupus nephritis.
Read the article published in LSM - https://doi.org/10.1136/lupus-2024-001351
11,143 Listeners
40 Listeners
4 Listeners
52 Listeners
7 Listeners
5 Listeners
3 Listeners
3 Listeners
4 Listeners
11 Listeners
38 Listeners
14 Listeners
1 Listeners
48 Listeners
0 Listeners
6 Listeners
496 Listeners
281 Listeners
3,336 Listeners
3 Listeners
90 Listeners
24 Listeners
1,095 Listeners
1,682 Listeners
23 Listeners
349 Listeners
23 Listeners
30 Listeners
366 Listeners
43 Listeners
2 Listeners
0 Listeners
0 Listeners
2 Listeners